SENZA.ST
SenzaGen AB
Price:  
6.95 
SEK
Volume:  
23,635.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SENZA.ST EV/EBITDA

-179.3%
Upside

As of 2024-12-11, the EV/EBITDA ratio of SenzaGen AB (SENZA.ST) is -13.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SENZA.ST's latest enterprise value is 166.39 mil SEK. SENZA.ST's TTM EBITDA according to its financial statements is -12.58 mil SEK. Dividing these 2 quantities gives us the above SENZA.ST EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.6x - 18.4x 13.0x
Forward P/E multiples 15.9x - 19.7x 19.0x
Fair Price (5.46) - (6.52) (5.51)
Upside -178.6% - -193.8% -179.3%
6.95 SEK
Stock Price
(5.51) SEK
Fair Price

SENZA.ST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-10 -13.23
2024-12-09 -13.23
2024-12-06 -13.58
2024-12-05 -13.11
2024-12-04 -13.70
2024-12-03 -13.93
2024-12-02 -14.28
2024-11-29 -13.23
2024-11-28 -13.46
2024-11-27 -13.46
2024-11-26 -13.70
2024-11-25 -13.81
2024-11-22 -13.70
2024-11-21 -13.35
2024-11-20 -13.35
2024-11-19 -13.81
2024-11-18 -13.70
2024-11-15 -13.93
2024-11-14 -13.81
2024-11-13 -13.58
2024-11-12 -13.70
2024-11-11 -14.05
2024-11-08 -14.64
2024-11-07 -13.93
2024-11-06 -13.93
2024-11-05 -13.70
2024-11-04 -14.05
2024-11-01 -14.17
2024-10-31 -13.70
2024-10-30 -13.81
2024-10-29 -14.99
2024-10-28 -14.52
2024-10-25 -14.64
2024-10-24 -13.93
2024-10-23 -14.05
2024-10-22 -14.52
2024-10-21 -14.75
2024-10-18 -14.17
2024-10-17 -14.17
2024-10-16 -14.28
2024-10-15 -14.52
2024-10-14 -14.52
2024-10-11 -14.87
2024-10-10 -14.40
2024-10-09 -14.75
2024-10-08 -14.99
2024-10-07 -14.75
2024-10-04 -14.52
2024-10-03 -14.40
2024-10-02 -14.52